Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan Xing

Showing results (861-870 of 914) with videos related to

Pageof 92
Sort By:
Experimental & Molecular Medicine|June 27, 2022
LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcriptionXiao-Jing Luo, Ming-Ming He, Jia Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2021
Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated DiseaseClaire L Langrish, J Michael Bradshaw, Michelle R Francesco, et al.
Antiviral Research|November 11, 2005
Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infectionYan-Xing Han, Rong Xue, Wei Zhao, et al.
JMIR Research Protocols|November 18, 2025
Cardio-Cerebral Protective Effect of Moxibustion on Phlegm-Dampness Type Hypertension: Protocol for a Randomized Controlled TrialLing Cheng, Ning Bai, Liang Zheng, et al.
Human Pathology|February 22, 2011
Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiationZhen Tian, Bing Wei, Feng Tang, et al.
Cancer|November 17, 2005
Angiosarcoma of the breastStephan A Vorburger, Yan Xing, Kelly K Hunt, et al.
Nature Communications|April 30, 2025
Inhibition of MBTPS1 enhances antitumor immunity and potentiates anti-PD-1 immunotherapyYi-Yu Wang, Jin-Fei Lin, Wen-Wei Wu, et al.
Nano Letters|March 31, 2025
Deteriorated Interlayer Coupling in Twisted Bilayer CobaltitesDongke Rong, Xiuqi Chen, Shengru Chen, et al.
Molecular Cancer Therapeutics|October 6, 2017
The Irreversible Covalent Fibroblast Growth Factor Receptor Inhibitor PRN1371 Exhibits Sustained Inhibition of FGFR after Drug ClearanceEleni Venetsanakos, Ken A Brameld, Vernon T Phan, et al.
Journal of Medicinal Chemistry|May 7, 2008
Benzoylurea derivatives as a novel class of antimitotic agents: synthesis, anticancer activity, and structure-activity relationshipsDan-Qing Song, Yan Wang, Lian-Zong Wu, et al.
Pageof 92

Showing results (861-870 of 914) with videos related to

Sort By:
Pageof 92
Experimental & Molecular Medicine|June 27, 2022
LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcriptionXiao-Jing Luo, Ming-Ming He, Jia Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2021
Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated DiseaseClaire L Langrish, J Michael Bradshaw, Michelle R Francesco, et al.
Antiviral Research|November 11, 2005
Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infectionYan-Xing Han, Rong Xue, Wei Zhao, et al.
JMIR Research Protocols|November 18, 2025
Cardio-Cerebral Protective Effect of Moxibustion on Phlegm-Dampness Type Hypertension: Protocol for a Randomized Controlled TrialLing Cheng, Ning Bai, Liang Zheng, et al.
Human Pathology|February 22, 2011
Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiationZhen Tian, Bing Wei, Feng Tang, et al.
Cancer|November 17, 2005
Angiosarcoma of the breastStephan A Vorburger, Yan Xing, Kelly K Hunt, et al.
Nature Communications|April 30, 2025
Inhibition of MBTPS1 enhances antitumor immunity and potentiates anti-PD-1 immunotherapyYi-Yu Wang, Jin-Fei Lin, Wen-Wei Wu, et al.
Nano Letters|March 31, 2025
Deteriorated Interlayer Coupling in Twisted Bilayer CobaltitesDongke Rong, Xiuqi Chen, Shengru Chen, et al.
Molecular Cancer Therapeutics|October 6, 2017
The Irreversible Covalent Fibroblast Growth Factor Receptor Inhibitor PRN1371 Exhibits Sustained Inhibition of FGFR after Drug ClearanceEleni Venetsanakos, Ken A Brameld, Vernon T Phan, et al.
Journal of Medicinal Chemistry|May 7, 2008
Benzoylurea derivatives as a novel class of antimitotic agents: synthesis, anticancer activity, and structure-activity relationshipsDan-Qing Song, Yan Wang, Lian-Zong Wu, et al.
Pageof 92